Navigation Links
Cadient Group Brings Home the Gold and Two Bronze Aster Awards

Interactive Agency Recognized for Excellence in Healthcare Marketing

WEST CONSHOHOCKEN, Pa., June 8 /PRNewswire/ -- Cadient Group, the premier strategic interactive marketing agency serving the healthcare industry, today announced that it was honored at the 2009 Aster Awards with the Gold and two Bronze awards for three of its recent healthcare marketing campaigns for DePuy Orthopaedics and AstraZeneca.

"We are honored to be recognized by a group of distinguished healthcare marketing experts for our work on these three projects," said Stephen Wray, president and CEO, Cadient Group. "We are committed to partnering with our clients to strategically design digital campaigns that are not only relevant and innovative, but that also deliver measurable results for our clients."

Presented by Marketing Healthcare Today magazine, the Aster Awards Program is an elite competition recognizing the nation's most talented healthcare marketing professionals for outstanding excellence in advertising. Judged by a diverse panel of experts, Cadient Group was recognized for the following three projects:

  • DePuy Orthopaedics-Gold

Cadient Group won the Gold in the Web site category for the Hip Replacement Web site it developed for DePuy Orthopaedics. Cadient Group redesigned and re-architected, as well as created an eCRM program to coincide with the launch of the site, resulting in increased traffic to the Web site.

  • AstraZeneca-Bronze

The agency was honored with a Bronze in the Total Advertising Campaigns' category for its Symbicort Consumer Campaign for AstraZeneca in Wilmington, Del. Cadient Group developed a successful launch campaign of the Symbicort brand to consumers, generating strong, early awareness of the new inhaled asthma therapy.

  • AstraZeneca-Bronze

Cadient Group was also recognized with a Bronze in the Special Video Production category for its "LOE Documentary = Living on the Edge" also for AstraZeneca. Created as an educational tool to explain bipolar disorder to the AstraZeneca sales force, this video struck a deep emotional chord and received extremely positive feedback.

About Cadient Group

Cadient Group is an interactive marketing network focused on the healthcare industry. Our companies align client needs with relevant innovation to deliver meaningful experiences and measurable results. Across Cadient Group, our strategic insight helps clients better utilize multi-channel marketing to enhance connections with consumer and professional audiences. Cadient Group clients consistently realize the full potential of their brand, franchise, and corporate healthcare communications. With Cadient Group, you'll Experience Results. For more information about Cadient Group, visit

    Media Contacts:
    Michael Walsh
    Sr. Director, Marketing Communications
    Cadient Group

    Karen Higgins
    A & E Communications, Inc. for Cadient Group

SOURCE Cadient Group
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Cadient Interactive Expands Creative Leadership with New Associate Director
2. Cadient Groups GEL Interactive Technologies to Launch Immerse(SM) Exhibit 4.0 at EXHIBITOR2009
3. Cadient Groups GEL Interactive Technologies to Present and Exhibit at CBIs 5th Annual Forum
4. Cadient Group Recognized with Five Awards at 14th Annual Communicator Awards
5. Cadient Group Brings Home the Gold at 2008 Aster Awards
6. Cadient Group Announces Recent Executive Promotions
7. AccuVein Inks National Three-Year Group Purchasing Deal With Amerinet
8. Optimal Reading Services Group, Inc. Receives Investment from Health Evolution Partners
9. Optimer Pharmaceuticals Announces Lower Recurrence Rates for Fidaxomicin Versus Vancocin(R) in Subgroup Analyses from Its Phase 3 Study for the Treatment of CDI
10. UCB and Crohns Disease Working Group Award $175,000 in Research Grants to Gastroenterology Fellows
11. Disabled and other vulnerable groups more susceptible to terrorism fears
Post Your Comments:
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/23/2016)... Seattle, WA (PRWEB) , ... June 23, 2016 ... ... technology, announces the release of its second eBook, “Clinical Trials Patient Recruitment and ... patient recruitment and retention in this eBook by providing practical tips, tools, and ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
(Date:6/23/2016)... ... June 23, 2016 , ... Charm ... Mold) microbial test has received AOAC Research Institute approval 061601. , “This is ... last year,” stated Bob Salter, Vice President of Regulatory and Industrial Affairs. “The ...
Breaking Biology Technology:
(Date:4/13/2016)... , April 13, 2016  IMPOWER physicians supporting Medicaid ... setting a new clinical standard in telehealth thanks to ... leveraging the higi platform, IMPOWER patients can routinely track ... and body mass index, and, when they opt in, ... convenient visit to a local retail location at no ...
(Date:3/29/2016)... LegacyXChange, Inc. (OTC: LEGX ... Protect are pleased to announce our successful effort to ... of writing instruments, ensuring athletes signatures against counterfeiting and ... athletes on LegacyXChange will be assured of ongoing proof ... Bill Bollander , CEO states, "By inserting ...
(Date:3/22/2016)... , PROVO and ... Newborn Screening Ontario (NSO), which operates the highest sample ... molecular testing, and Tute Genomics and UNIConnect, leaders in ... respectively, today announced the launch of a project to ... (NGS) testing panel. NSO has been ...
Breaking Biology News(10 mins):